Pasar al contenido principal

Resultados relacionados

Resultados totales (Incluyendo duplicados): 2
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Bacterial-mediated Selenium Nanoparticles as Highly Selective Antimicrobial Agents with Anticancer Properties

  • Medina Cruz, David
  • Truong, Linh B.
  • Sotelo, Eduardo
  • Martínez Orellana, Lidia
  • González Sagardoy, María Ujué
  • Huttel, Yves
  • Webster, Thomas J.
  • García-Martín, José Miguel
  • Cholula-Díaz, Jorge L.
The green synthesis of nanomaterials offers advantages over traditional chemical methods, such as the production of biocompatible nanostructures in an environmentally friendly and cost-effective manner. Among all of the available green synthesis routes, the use of bacteria offers a high-throughput and versatile synthesis of nanoparticles that can be used in a wide range of biomedical approaches. In this article, we present a controllable and versatile synthesis of selenium nanoparticles (SeNPs) using bacterial isolates of both Gram negative and Gram positive bacteria. The SeNPs were characterized in terms of their physicochemical properties and tested in both antimicrobial and cytotoxicity assays, showing a selective dose-dependent antibacterial activity in a selected range of concentrations (especially when SeNPs synthesized by a particular bacterial isolate were exposed to that isolate) and a mild cytotoxicity when exposed to human dermal fibroblasts. Furthermore, the SeNPs were tested for their anticancer activity by exposure to melanoma cells (skin cancer) in in vitro models, showing a significant dose¿response cytotoxic behavior that was associated to the production of reactive oxygen species. Therefore, this work presents a robust and versatile method to produce SeNPs using selected bacterial isolates for numerous biomedical applications., The authors from Tecnologico de Monterrey and CSIC thank the bilateral project BILTC22001 for funding. The authors from Tecnologico de Monterrey also thank the Department of Sciences – Chemistry and Nanotechnology at Tecnologico de Monterrey, campus Monterrey. TJW thanks Art Zaropoulo for funding. The authors acknowledge the service from the MiNa Laboratory at IMN, funded from CM (project SpaceTec, S2018/ NMT-4291 TEC2SPACE), MINECO (project CSIC13-4E-1794), and EU (FEDER, FSE)., Peer reviewed
Dipòsit Digital de Documents de la UAB
Publicación Artículo de revisión (ReviewArticle)

An evidence map of actigraphy studies exploring longitudinal associations between rest-activity rhythms and course and outcome of bipolar disorders

  • Scott, Jan
  • Colom, Francesc|||0000-0002-9516-9030
  • Young, Allan|||0000-0003-2291-6952
  • Bellivier, Frank
  • Etain, Bruno|||0000-0002-5377-1488
Evidence mapping is a structured approach used to synthesize the state-of-the-art in an emerging field of research when systematic reviews or meta-analyses are deemed inappropriate. We employed this strategy to summarise knowledge regarding longitudinal ecological monitoring of rest-activity rhythms (RAR) and disease modifiers, course of illness, treatment response or outcome in bipolar disorders (BD). We had two key aims: (1) to determine the number and type of actigraphy studies of in BD that explored data regarding: outcome over time (e.g. relapse/recurrence according to polarity, or recovery/remission), treatment response or illness trajectories and (2) to examine the range of actigraphy metrics that can be used to estimate disruptions of RAR and describe which individual circadian rhythm or sleep-wake cycle parameters are most consistently associated with outcome over time in BD. The mapping process incorporated four steps: clarifying the project focus, describing boundaries and 'coordinates' for mapping, searching the literature and producing a brief synopsis with summary charts of the key outputs. Twenty-seven independent studies (reported in 29 publications) were eligible for inclusion in the map. Most were small-scale, with the median sample size being 15 per study and median duration of actigraphy being about 7 days (range 1-210). Interestingly, 17 studies comprised wholly or partly of inpatients (63%). The available evidence indicated that a discrete number of RAR metrics are more consistently associated with transition between different phases of BD and/or may be predictive of longitudinal course of illness or treatment response. The metrics that show the most frequent associations represent markers of the amount, timing, or variability of RAR rather than the sleep quality metrics that are frequently targeted in contemporary studies of BD. Despite 50 years of research, use of actigraphy to assess RAR in longitudinal studies and examination of these metrics and treatment response, course and outcome of BD is under-investigated. This is in marked contrast to the extensive literature on case-control or cross-sectional studies of actigraphy, especially typical sleep analysis metrics in BD. However, given the encouraging findings on putative RAR markers, we recommend increased study of putative circadian phenotypes of BD.